The circadian rhythm of the liver is regulated by muscle activity

by IRB Barcelona - Instituto de Investigación Biomédica

3 years ago
central nervous system, circadian rhythm, liver

Researchers at IRB Barcelona reveal a communication pathway between the biological clock of organs and tissues that is independent of regulation by the central nervous system. Alterations of the circ...

Researchers in IMIM show that cholesterol is fundamental for signal transmission in the human brain

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

3 years ago
central nervous system, serotonin receptor, cholesterol

Researchers from the Hospital del Mar Medical Research Institute (IMIM) have discovered a novel mechanism through which the serotonin receptor interacts with cell membranes in the human brain. This fi...

60% of Covid-19 patients develop neurological symptoms

by Hospital Universitari de Bellvitge

3 years ago
neurological symptoms, Covid-19, central nervous system

60% of Covid-19 inpatients develop neurological symptoms and 12% of post-Covid patients have neurological sequelae, according to a panel discussion at the 2nd Covid-19 Multidisciplinary Congress moder...

Synendos Therapeutics Expands Series A to CHF 24 million with new investment. Ysios Capital joins other investors

by Ysios Capital

3 years ago
Ysios Capital, Eurostars Funding Programme, SERIs, Synendos Therapeutics, Central Nervous System

Synendos Therapeutics (Synendos), a biopharmaceutical company focused on restoring the natural functioning of the endocannabinoid system to treat Central Nervous System (CNS) disorders, today annou...

La Vanguardia published a press release: 'The future of biotechnology: lower-cost treatments in a short period of time'

by Som Biotech

3 years ago
Central Nervous System, La Vanguardia, biotechnology, Artificial Intelligence, rare diseases

SOM Biotech has designed a computational Artificial Intelligence-based method to analyze molecular structures and select the best option after performing more than 2.5 million comparisons in each p...

Alta Life Sciences and CDTI invest €7.6M in Accure Therapeutics, a new company that will develop a portfolio of new medicines to address CNS diseases

by Alta Life Sciences / CDTI

4 years ago
Alta Life Sciences, CDTI, Accure Therapeutics, drugs, Central Nervous System

Accure Therapeutics, a new pharma R&D player in the Central Nervous System (CNS) field, announces today its launch with a Series A round of funding totalling €7.6 million ($8.1M). The funding round ...

Minoryx Therapeutics doses first patient with leriglitazone in registration-enabling cALD NEXUS trial

by Minoryx Therapeutics

4 years ago
pediatric, Central Nervous System, leriglitazone

Pediatric Investigational Plan (PIP) for leriglitazone in X-ALD approved by EMA, allowing to file Marketing Authorization Application (MAA) in Europe based on NEXUS

Minoryx Therapeutics receives US FDA fast-track designation for leriglitazone in the treatment of X-ALD

by Minoryx Therapeutics

4 years ago
Central Nervous System, drug, Friedreich’s Ataxia, neuroscience

Leriglitazone (MIN-102), a novel, brain penetrant, orally bioavailable and selective PPARγ agonist, is currently in late-stage development for treatment of severe orphan CNS disorders, including X-AL...

A new experimental model to promote research on the neurological illness of Niemann-Pick type C

by Universitat de Barcelona

7 years ago
Niemann-Pick type C, central nervous system, lipids

Niemann-Pick type C disease is a progressive serious neurological illness which causes accumulation of lipids in the central nervous system and several organs of the body, such as the liver and the sp...

A bee’s poison component can help improving drugs that treat brain diseases

by Universitat de Barcelona

7 years ago
peptide, bee’s poison, central nervous system, molecule shuttle, neurotoxin

A molecule, in particular a peptide designed out of bee’s poison, can become an important contribution to increase the efficiency of drugs treating the central nervous system. The research by Benjam...

VHIR creates the Spina Bifida Transversal Research Programme

by Vall d’Hebron

7 years ago
Spina bifida, neural tube defects, myelomeningocele, central nervous system

Spina bifida is the colloquial name by which neural tube defects are known. The most severe open form of neural tube defect compatible with life is the myelomeningocele, which implies affectation of t...

Neuron BioServices helps its clients to identify new drugs and ingredients able to face neuronal disorders and to improve learning and memory processes

by Neuron Bio

10 years ago
central nervous system

March 24th 2014 - Neuron Bioservices has developed a method to assay neurite outgrowth with differentiated neuronal cells to study neuroplasticity. The nervous system is an intricate network...